Logo image of AKBA

AKEBIA THERAPEUTICS INC (AKBA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:AKBA - US00972D1054 - Common Stock

1.36 USD
+0.02 (+1.49%)
Last: 1/16/2026, 8:00:00 PM
1.37 USD
+0.01 (+0.74%)
After Hours: 1/16/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AKBA revenue by date.AKBA revenue by date.
292.5M
38.17%
194.623M
-33.46%
160.18M
-17.70%
244.09M
52.38%
298.89M
22.45%
329.23M
10.15%
395.77M
20.21%
446.63M
12.85%
510.63M
14.33%
559.69M
9.61%
594.59M
6.24%
630.87M
6.10%
EBITDA
YoY % growth
AKBA ebitda by date.AKBA ebitda by date.
2.99M
101.41%
-6.848M
-329.03%
-8.71M
-27.19%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AKBA ebit by date.AKBA ebit by date.
-34.7M
86.09%
-44.475M
-28.17%
-46.214M
-3.91%
35.544M
176.91%
57.446M
61.62%
83.143M
44.73%
113.83M
36.91%
171.15M
50.36%
267.15M
56.09%
307.4M
15.07%
335.19M
9.04%
363.74M
8.52%
Operating Margin
AKBA operating margin by date.AKBA operating margin by date.
-11.86%-22.85%-28.85%14.56%19.22%25.25%28.76%38.32%52.32%54.92%56.37%57.66%
EPS
YoY % growth
AKBA eps by date.AKBA eps by date.
-0.44
74.12%
-0.28
36.36%
-0.33
-17.86%
0.04
113.60%
0.11
155.68%
0.19
62.96%
0.34
82.73%
0.40
16.42%
0.52
30.77%
0.62
19.61%
0.72
16.39%
0.84
15.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.01
92.35%
-0.01
-134.00%
0.000.010.05
722.27%
Revenue
Q2Q % growth
57.303M
23.24%
60.515M
5.54%
68.096M
9.00%
76.665M
30.46%
91.659M
59.95%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
2.675M
121.39%
3.738M
-72.74%
7.347M
-47.48%
10.538M
112.93%
20.121M
652.19%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.00
100.00%
-0.020.02100.00%
Q2 2025
Q2Q % growth
0.00
100.00%
-0.020.02100.00%
Q1 2025
Q2Q % growth
0.03
133.33%
-0.050.08165.36%
Q4 2024
Q2Q % growth
-0.10 -0.08-0.02-22.55%
Q3 2024
Q2Q % growth
-0.10
-25.00%
-0.06-0.04-54.81%
Q2 2024
Q2Q % growth
-0.04
33.33%
-0.050.0126.47%
Q1 2024
Q2Q % growth
-0.09
35.71%
-0.08-0.01-15.08%
Q4 2023
Q2Q % growth
0.00
100.00%
-0.040.04100.00%
Q3 2023
Q2Q % growth
-0.08
71.43%
-0.090.017.73%
Q2 2023
Q2Q % growth
-0.06
-126.09%
-0.03-0.03-135.29%
Q1 2023
Q2Q % growth
-0.14
60.00%
-0.150.018.50%
Q4 2022
Q2Q % growth
-0.04
90.00%
-0.190.1578.99%
Q3 2022
Q2Q % growth
-0.28
17.65%
-0.15-0.13-83.01%
Q2 2022
Q2Q % growth
0.23
145.10%
-0.320.55171.76%
Q1 2022
Q2Q % growth
-0.35
22.22%
-0.29-0.06-19.01%
Q4 2021
Q2Q % growth
-0.40
33.33%
-0.34-0.06-19.35%
Q3 2021
Q2Q % growth
-0.34
19.05%
-0.32-0.02-5.26%
Q2 2021
Q2Q % growth
-0.51
-15.91%
-0.32-0.19-58.10%
Q1 2021
Q2Q % growth
-0.45
4.26%
-0.30-0.15-50.19%
Q4 2020
Q2Q % growth
-0.60 -0.41-0.19-46.53%
Q3 2020
Q2Q % growth
-0.42 -0.18-0.24-138.70%
Q2 2020
Q2Q % growth
-0.44 -0.510.0713.29%
Q1 2020
Q2Q % growth
-0.47 -0.630.1625.53%
AKBA Yearly EPS VS EstimatesAKBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
58.766M
57.01%
59.4M-634K-1.07%
Q2 2025
Q2Q % growth
62.472M
43.13%
48.182M14.29M29.66%
Q1 2025
Q2Q % growth
57.336M
75.84%
45.78M11.556M25.24%
Q4 2024
Q2Q % growth
46.497M
-17.26%
38.096M8.401M22.05%
Q3 2024
Q2Q % growth
37.428M
-10.98%
45.397M-7.969M-17.55%
Q2 2024
Q2Q % growth
43.648M
-22.58%
50.439M-6.791M-13.46%
Q1 2024
Q2Q % growth
32.607M
-18.74%
47.008M-14.401M-30.64%
Q4 2023
Q2Q % growth
56.196M
1.99%
56.501M-305K-0.54%
Q3 2023
Q2Q % growth
42.046M
-13.66%
49.147M-7.101M-14.45%
Q2 2023
Q2Q % growth
56.376M
-55.40%
60.282M-3.906M-6.48%
Q1 2023
Q2Q % growth
40.127M
-34.86%
47.618M-7.491M-15.73%
Q4 2022
Q2Q % growth
55.1M
-4.51%
48.347M6.753M13.97%
Q3 2022
Q2Q % growth
48.7M
-0.20%
48.111M589K1.22%
Q2 2022
Q2Q % growth
126.4M
138.94%
50.725M75.675M149.19%
Q1 2022
Q2Q % growth
61.6M
17.78%
45.108M16.492M36.56%
Q4 2021
Q2Q % growth
57.7M
3.04%
51.819M5.881M11.35%
Q3 2021
Q2Q % growth
48.8M
-18.67%
50.663M-1.863M-3.68%
Q2 2021
Q2Q % growth
52.9M
-41.29%
53.925M-1.025M-1.90%
Q1 2021
Q2Q % growth
52.3M
-40.90%
56.832M-4.532M-7.97%
Q4 2020
Q2Q % growth
56M 52.181M3.819M7.32%
Q3 2020
Q2Q % growth
60M 86.594M-26.594M-30.71%
Q2 2020
Q2Q % growth
90.1M 75.668M14.432M19.07%
Q1 2020
Q2Q % growth
88.5M 79.031M9.469M11.98%
AKBA Yearly Revenue VS EstimatesAKBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 46.43% 0% 300%
Revenue0% 3.84% 0% 5.89%